These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 20870029)

  • 21. Higher CD34(+) and CD3(+) cell doses in the graft promote long-term survival, and have no impact on the incidence of severe acute or chronic graft-versus-host disease after in vivo T cell-depleted unrelated donor hematopoietic stem cell transplantation in children.
    Kałwak K; Porwolik J; Mielcarek M; Gorczyńska E; Owoc-Lempach J; Ussowicz M; Dyla A; Musiał J; Paździor D; Turkiewicz D; Chybicka A
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1388-401. PubMed ID: 20382248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
    de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors influencing outcome and incidence of late complications in children who underwent allogeneic hematopoietic stem cell transplantation for hemoglobinopathy.
    Khalil A; Zaidman I; Elhasid R; Peretz-Nahum M; Futerman B; Ben-Arush M
    Pediatr Hematol Oncol; 2012 Nov; 29(8):694-703. PubMed ID: 23020512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health-related quality of life in patients undergoing allogeneic stem cell transplantation after reduced intensity conditioning versus myeloablative conditioning.
    Andersson I; Ahlberg K; Stockelberg D; Brune M; Persson LO
    Cancer Nurs; 2009; 32(4):325-34. PubMed ID: 19444087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients.
    La Nasa G; Littera R; Locatelli F; Giardini C; Ventrella A; Mulargia M; Vacca A; Orrù N; Orrù S; Piras E; Giustolisi G; Lisini D; Nesci S; Caocci G; Carcassi C
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1358-68. PubMed ID: 17950922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
    Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporin A and mini short-term methotrexate vs cyclosporin A as graft-versus-host disease prophylaxis in patients with beta thalassemia major undergoing allogeneic blood and marrow transplantation.
    Iravani M; Mousavi A; Gholibeikian S; Bahar B; Samiee S; Ashouri A; Eghbal L; Ghavamzadeh A
    Bone Marrow Transplant; 2005 Jun; 35(11):1095-9. PubMed ID: 15821773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychometric properties of the Swedish PedsQL, Pediatric Quality of Life Inventory 4.0 generic core scales.
    Petersen S; Hägglöf B; Stenlund H; Bergström E
    Acta Paediatr; 2009 Sep; 98(9):1504-12. PubMed ID: 19570060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV.
    Remberger M; Naseh N; Aschan J; Barkholt L; LeBlanc K; Svennberg P; Ringdén O
    Bone Marrow Transplant; 2003 Jul; 32(2):217-23. PubMed ID: 12838288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parent proxy-reported health-related quality of life and fatigue in pediatric patients diagnosed with brain tumors and acute lymphoblastic leukemia.
    Meeske K; Katz ER; Palmer SN; Burwinkle T; Varni JW
    Cancer; 2004 Nov; 101(9):2116-25. PubMed ID: 15389475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-related quality of life in pediatric patients with long-standing pancreatitis.
    Pohl JF; Limbers CA; Kay M; Harman A; Rollins M; Varni JW
    J Pediatr Gastroenterol Nutr; 2012 May; 54(5):657-63. PubMed ID: 22094900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
    Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematopoietic stem cell transplantation for children with thalassemia major in China.
    Fang JP; Xu LH
    Pediatr Blood Cancer; 2010 Dec; 55(6):1062-5. PubMed ID: 20979169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective evaluation of health related quality of life for pediatric patients with ureteropelvic junction obstruction.
    Parekh AD; Thomas JC; Trusler L; Ankerst DP; Deshpande JK; Adams MC; Pope JC; Brock JW
    J Urol; 2008 Nov; 180(5):2171-5; discussion 2175-6. PubMed ID: 18804796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen.
    Resnick IB; Aker M; Tsirigotis P; Shapira MY; Abdul-Hai A; Bitan M; Gesundheit B; Amar A; Ackerstein A; Samuel S; Slavin S; Or R
    Bone Marrow Transplant; 2007 Nov; 40(10):957-64. PubMed ID: 17846604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular immune reconstitution and its impact on clinical outcome in children with beta thalassemia major undergoing a matched related myeloablative allogeneic bone marrow transplant.
    Rajasekar R; Mathews V; Lakshmi KM; George B; Viswabandya A; Chandy M; Srivastava A
    Biol Blood Marrow Transplant; 2009 May; 15(5):597-609. PubMed ID: 19361752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD.
    Levine JE; Wiley J; Kletzel M; Yanik G; Hutchinson RJ; Koehler M; Neudorf S
    Bone Marrow Transplant; 2000 Jan; 25(1):13-8. PubMed ID: 10654008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
    Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
    Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
    Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
    Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.